Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Predictability of anthrax infection in the Serengeti, Tanzania.

Hampson K, Lembo T, Bessell P, Auty H, Packer C, Halliday J, Beesley CA, Fyumagwa R, Hoare R, Ernest E, Mentzel C, Metzger KL, Mlengeya T, Stamey K, Roberts K, Wilkins PP, Cleaveland S.

J Appl Ecol. 2011 Jun 10;48(6):1333-1344.

2.

Serologic surveillance of anthrax in the Serengeti ecosystem, Tanzania, 1996-2009.

Lembo T, Hampson K, Auty H, Beesley CA, Bessell P, Packer C, Halliday J, Fyumagwa R, Hoare R, Ernest E, Mentzel C, Mlengeya T, Stamey K, Wilkins PP, Cleaveland S.

Emerg Infect Dis. 2011 Mar;17(3):387-94. doi: 10.3201/eid1703.101290.

3.

Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial.

Marano N, Plikaytis BD, Martin SW, Rose C, Semenova VA, Martin SK, Freeman AE, Li H, Mulligan MJ, Parker SD, Babcock J, Keitel W, El Sahly H, Poland GA, Jacobson RM, Keyserling HL, Soroka SD, Fox SP, Stamper JL, McNeil MM, Perkins BA, Messonnier N, Quinn CP; Anthrax Vaccine Research Program Working Group..

JAMA. 2008 Oct 1;300(13):1532-43. doi: 10.1001/jama.300.13.1532. Erratum in: JAMA. 2008 Nov 19;300(19):2252.

PMID:
18827210
4.

Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization.

Li H, Soroka SD, Taylor TH Jr, Stamey KL, Stinson KW, Freeman AE, Abramson DR, Desai R, Cronin LX, Oxford JW, Caba J, Pleatman C, Pathak S, Schmidt DS, Semenova VA, Martin SK, Wilkins PP, Quinn CP.

J Immunol Methods. 2008 Apr 20;333(1-2):89-106. doi: 10.1016/j.jim.2008.01.007. Epub 2008 Feb 8.

PMID:
18304568
5.

Detection and quantification of anthrax lethal factor in serum by mass spectrometry.

Boyer AE, Quinn CP, Woolfitt AR, Pirkle JL, McWilliams LG, Stamey KL, Bagarozzi DA, Hart JC Jr, Barr JR.

Anal Chem. 2007 Nov 15;79(22):8463-70. Epub 2007 Oct 12.

PMID:
17929949
6.

Cryptococcus gattii infection: characteristics and epidemiology of cases identified in a South African province with high HIV seroprevalence, 2002-2004.

Morgan J, McCarthy KM, Gould S, Fan K, Arthington-Skaggs B, Iqbal N, Stamey K, Hajjeh RA, Brandt ME; Gauteng Cryptococcal Surveillance Initiative Group..

Clin Infect Dis. 2006 Oct 15;43(8):1077-80. Epub 2006 Sep 5.

PMID:
16983624
7.

Invasive infection with multidrug-resistant Salmonella enterica serotype typhimurium definitive type 104 among HIV-infected adults.

Fisk TL, Lundberg BE, Guest JL, Ray S, Barrett TJ, Holland B, Stamey K, Angulo FJ, Farley MM.

Clin Infect Dis. 2005 Apr 1;40(7):1016-21. Epub 2005 Feb 24.

PMID:
15824994
8.

Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum.

Semenova VA, Steward-Clark E, Stamey KL, Taylor TH Jr, Schmidt DS, Martin SK, Marano N, Quinn CP.

Clin Diagn Lab Immunol. 2004 Sep;11(5):919-23.

9.

Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax.

Quinn CP, Dull PM, Semenova V, Li H, Crotty S, Taylor TH, Steward-Clark E, Stamey KL, Schmidt DS, Stinson KW, Freeman AE, Elie CM, Martin SK, Greene C, Aubert RD, Glidewell J, Perkins BA, Ahmed R, Stephens DS.

J Infect Dis. 2004 Oct 1;190(7):1228-36. Epub 2004 Aug 30.

PMID:
15346332
10.

Multidrug-resistant strains of Salmonella enterica Typhimurium, United States, 1997-1998.

Rabatsky-Ehr T, Whichard J, Rossiter S, Holland B, Stamey K, Headrick ML, Barrett TJ, Angulo FJ; NARMS Working Group..

Emerg Infect Dis. 2004 May;10(5):795-801.

11.

Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins.

Biagini RE, Sammons DL, Smith JP, MacKenzie BA, Striley CA, Semenova V, Steward-Clark E, Stamey K, Freeman AE, Quinn CP, Snawder JE.

Clin Diagn Lab Immunol. 2004 Jan;11(1):50-5.

12.

Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen.

Quinn CP, Semenova VA, Elie CM, Romero-Steiner S, Greene C, Li H, Stamey K, Steward-Clark E, Schmidt DS, Mothershed E, Pruckler J, Schwartz S, Benson RF, Helsel LO, Holder PF, Johnson SE, Kellum M, Messmer T, Thacker WL, Besser L, Plikaytis BD, Taylor TH Jr, Freeman AE, Wallace KJ, Dull P, Sejvar J, Bruce E, Moreno R, Schuchat A, Lingappa JR, Martin SK, Walls J, Bronsdon M, Carlone GM, Bajani-Ari M, Ashford DA, Stephens DS, Perkins BA.

Emerg Infect Dis. 2002 Oct;8(10):1103-10.

13.

Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC beta-lactamase.

Dunne EF, Fey PD, Kludt P, Reporter R, Mostashari F, Shillam P, Wicklund J, Miller C, Holland B, Stamey K, Barrett TJ, Rasheed JK, Tenover FC, Ribot EM, Angulo FJ.

JAMA. 2000 Dec 27;284(24):3151-6.

PMID:
11135779
14.

The National Antimicrobial Resistance Monitoring System (NARMS) for enteric bacteria, 1996-1999: surveillance for action.

Marano NN, Rossiter S, Stamey K, Joyce K, Barrett TJ, Tollefson LK, Angulo FJ.

J Am Vet Med Assoc. 2000 Dec 15;217(12):1829-30. Review. No abstract available.

PMID:
11132885

Supplemental Content

Loading ...
Support Center